In details, the combined effect of PNPLA3 and TM6SF2 mutations seems to affect lipid metabolism and NAFLD possibly by exacerbating the expression of genes involved in DNL [244]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.